Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Biochemical Society Transactions

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1042/BST20120054PMID 22988865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of TAE684 as a potent LRRK2 kinase inhibitor.

  2012cited by this paper
• LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth

  2012cited by this paper
• Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2

  2011cited by this paper
• Characterization of a selective inhibitor of the Parkinson’s disease kinase LRRK2

  2011cited by this paper
• Autophosphorylation in the leucine-rich repeat kinase 2 (LRRK2) GTPase domain modifies kinase and GTP-binding activities.

  2011cited by this paper
• Kinetic, mechanistic, and structural modeling studies of truncated wild-type leucine-rich repeat kinase 2 and the G2019S mutant.

  2011cited by this paper
• Insight into the mode of action of the LRRK2 Y1699C pathogenic mutant

  2011cited by this paper
• Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease.

  2011cited by this paper
• Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice.

  2011cited by this paper
• Rac1 Protein Rescues Neurite Retraction Caused by G2019S Leucine-rich Repeat Kinase 2 (LRRK2)*

  2011cited by this paper
• Milestones in PD genetics

  2011cited by this paper
• MKK6 binds and regulates expression of Parkinson’s disease‐related protein LRRK2

  2010cited by this paper
• A QUICK Screen for Lrrk2 Interaction Partners – Leucine-rich Repeat Kinase 2 is Involved in Actin Cytoskeleton Dynamics*

  2010cited by this paper
• Identification and Characterization of a Leucine-Rich Repeat Kinase 2 (LRRK2) Consensus Phosphorylation Motif

  2010cited by this paper
• GTPase Activity Plays a Key Role in the Pathobiology of LRRK2

  2010cited by this paper
• The Parkinson's Disease Associated LRRK2 Exhibits Weaker In Vitro Phosphorylation of 4E-BP Compared to Autophosphorylation

  2010cited by this paper
• Enhanced Striatal Dopamine Transmission and Motor Performance with LRRK2 Overexpression in Mice Is Eliminated by Familial Parkinson's Disease Mutation G2019S

  2010cited by this paper
• Phosphopeptide analysis reveals two discrete clusters of phosphorylation in the N-terminus and the Roc domain of the Parkinson-disease associated protein kinase LRRK2.

  2010cited by this paper
• LRRK2 and the Stress Response: Interaction with MKKs and JNK-Interacting Proteins

  2010cited by this paper
• Membrane localization of LRRK2 is associated with increased formation of the highly active LRRK2 dimer and changes in its phosphorylation.

  2010cited by this paper
• Inhibitors of Leucine Rich Repeat Kinase 2 (LRRK2) Protect Against LRRK2-Models of Parkinson’s Disease

  2010cited by this paper
• P3.191 LRRK2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications

  2009cited by this paper
• Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications.

  2009cited by this paper
• The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration

  2009cited by this paper
• Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease

  2009cited by this paper
• Identification of the autophosphorylation sites of LRRK2.

  2009cited by this paper
• Investigation of leucine‐rich repeat kinase 2

  2009cited by this paper
• Phosphorylation of Ezrin/Radixin/Moesin Proteins by LRRK2 Promotes the Rearrangement of Actin Cytoskeleton in Neuronal Morphogenesis

  2009cited by this paper
• Leucine‐rich repeat kinase 2 phosphorylates brain tubulin‐beta isoforms and modulates microtubule stability – a point of convergence in Parkinsonian neurodegeneration?

  2009cited by this paper
• The Parkinson disease‐associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro

  2009cited by this paper
• The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites.

  2009cited by this paper
• R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice

  2009cited by this paper
• Leucine-rich repeat kinase 2 mutations and Parkinson’s disease: three questions

  2009cited by this paper
• Dependence of Leucine-rich Repeat Kinase 2 (LRRK2) Kinase Activity on Dimerization*

  2009cited by this paper
• Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease.

  2009cited by this paper
• Phosphorylation of 4E‐BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila

  2008cited by this paper
• The Parkinson Disease-associated Leucine-rich Repeat Kinase 2 (LRRK2) Is a Dimer That Undergoes Intramolecular Autophosphorylation*

  2008cited by this paper
• The Roc domain of leucine‐rich repeat kinase 2 is sufficient for interaction with microtubules

  2008cited by this paper
• Kinase signaling pathways as potential targets in the treatment of Parkinson’s disease

  2007cited by this paper
• LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity.

  2007cited by this paper
• Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity.

  2007cited by this paper
• The R1441C mutation of LRRK2 disrupts GTP hydrolysis.

  2007cited by this paper
• Kinase activity of mutant LRRK2 mediates neuronal toxicity

  2006cited by this paper
• Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.

  2006cited by this paper
• The Parkinson disease gene LRRK2: evolutionary and structural insights.

  2006cited by this paper
• The RIP kinases: crucial integrators of cellular stress.

  2005cited by this paper
• ERBB receptors and cancer: the complexity of targeted inhibitors

  2005cited by this paper
• Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

  2004cited by this paper
• Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

  2004cited by this paper
• A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1

  2002cited by this paper
• ReportThe Familial Parkinsonism Gene LRRK 2 Regulates Neurite Process Morphology

  year unknowncited by this paper

• Microglial Sp1 induced LRRK2 upregulation in response to manganese exposure, and 17β-estradiol afforded protection against this manganese toxicity.

  2024cites this paper
• PAK6-mediated phosphorylation of PPP2R2C regulates LRRK2-PP2A complex formation

  2023cites this paper
• Altered neural cell junctions and ion-channels leading to disrupted neuron communication in Parkinson’s disease

  2022cites this paper
• LRRK2 and Proteostasis in Parkinson’s Disease

  2022cites this paper
• Exploring the focal role of LRRK2 kinase in Parkinson’s disease

  2022influential citation
• Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells

  2021cites this paper
• Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease

  2021cites this paper
• Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years.

  2021cites this paper
• LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?

  2020cites this paper
• The role of NLRC4 inflammasome on  intracerebral hemorrhage-caused inflammation in rats

  2020cites this paper
• Sleep Spindles and Fragmented Sleep as Prodromal Markers in a Preclinical Model of LRRK2-G2019S Parkinson's Disease

  2020cites this paper
• Leucine‐rich repeat kinase 2 phosphorylation on synapsin I regulates glutamate release at pre‐synaptic sites

  2019cites this paper
• LRRK2 kinase plays a critical role in manganese-induced inflammation and apoptosis in microglia

  2019cites this paper
• Peripheral-Central Neuroimmune Crosstalk in Parkinson's Disease: What Do Patients and Animal Models Tell Us?

  2019cites this paper
• 3D Cultures of Parkinson's Disease‐Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing

  2018cites this paper
• Title Combined LRRK 2 mutation , aging and chronic low dose oralrotenone as a model of Parkinson ’ s disease

  2017cites this paper
• Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson’s disease

  2017cites this paper
• LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease

  2017cites this paper
• Structural interface between LRRK2 and 14-3-3 protein.

  2017cites this paper
• Studying α-Synuclein pathology using iPSC-derived dopaminergic neurons

  2017cites this paper
• Stabilization of multivalent 14-3-3 protein-protein interactions

  2017cites this paper
• LRRK2 detection in human biofluids: potential use as a Parkinson's disease biomarker?

  2017cites this paper
• Parkinson disease–associated LRRK2 G2019S transgene disrupts marrow myelopoiesis and peripheral Th17 response

  2017cites this paper
• Novel LRRK2 substrates at the presynaptic site in vesicle recycling pathways in Parkinson's disease

  2016cites this paper
• Urinary LRRK2 phosphorylation

  2016cites this paper
• LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate

  2016cites this paper
• Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance

  2016cites this paper
• Leucine-Rich Repeat Kinase 2 Influences Fate Decision of Human Monocytes Differentiated from Induced Pluripotent Stem Cells

  2016cites this paper
• Leucine‐rich repeat kinase 2 interacts with p21‐activated kinase 6 to control neurite complexity in mammalian brain

  2015cites this paper
• Modulation of the expression and function of dopaminergic presynaptic proteins by the statins : Potential implication for the therapeutic intervention in Parkinson’s disease.

  2015cites this paper
• Chemical genetic approach identifies microtubule affinity‐regulating kinase 1 as a leucine‐rich repeat kinase 2 substrate

  2015cites this paper
• LRRK2 Promotes Tau Accumulation, Aggregation and Release

  2015cites this paper
• Molecular basis of Parkinsons’s disease linked to LRRK2 mutations

  2014cites this paper
• Investigating the Multiple Hit hypothesis of Parkinson disease using transgenic LRRK2-R1441G rats

  2014cites this paper
• Regulation and targeting of enzymes mediating Parkinson's disease pathogenesis: focus on Parkinson's disease kinases, GTPases, and ATPases

  2014influential citation
• Prediction of the Repeat Domain Structures and Impact of Parkinsonism‐Associated Variations on Structure and Function of all Functional Domains of Leucine‐Rich Repeat Kinase 2 (LRRK2)

  2014cites this paper
• LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis.

  2014cites this paper
• Inhibition of LRRK2 kinase activity stimulates macroautophagy

  2013cites this paper
• Genetic Insights into Sporadic Parkinson's Disease Pathogenesis

  2013cites this paper